Showing results (1-10 of 51) with videos related to
Sort By:
Pageof 6
Lung Cancer (Amsterdam, Netherlands)|November 21, 2001
Importance of weight loss definition in the prognostic evaluation of non-small-cell lung cancerG Buccheri, D FerrignoCancer|June 28, 2000
Vinorelbine in elderly patients with inoperable nonsmall cell lung carcinoma: a phase II studyG Buccheri, D FerrignoLung Cancer (Amsterdam, Netherlands)|October 1, 1995
Monitoring lung cancer with tissue polypeptide antigen: an ancillary, profitable serum test to evaluate treatment response and posttreatment disease statusG Buccheri, D FerrignoActa Oncologica (Stockholm, Sweden)|January 1, 1996
Is the MVP regimen less active than previously described? Results of a phase II study in advanced non-small cell lung cancerD Ferrigno, G BuccheriThe European Respiratory Journal|December 2, 2004
Lung cancer: clinical presentation and specialist referral timeG Buccheri, D FerrignoMonaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|April 7, 2004
Hematologic counts and clinical correlates in 1201 newly diagnosed lung cancer patientsD Ferrigno, G BuccheriLung Cancer (Amsterdam, Netherlands)|June 1, 1996
Therapeutic options for regionally advanced non-small cell lung cancerG Buccheri, D FerrignoBritish Journal of Cancer|October 29, 2002
Lung tumour markers in oncology practice: a study of TPA and CA125G Buccheri, D FerrignoEuropean Journal of Cancer (Oxford, England : 1990)|January 1, 1994
A randomised trial of MACC chemotherapy with or without lonidamine in advanced non-small cell lung cancer. Cuneo Lung Cancer Study Group (CuLCaSG)G Buccheri, D FerrignoLung Cancer (Amsterdam, Netherlands)|November 27, 2001
Lung tumor markers of cytokeratin origin: an overviewG Buccheri, D FerrignoPageof 6